News Directory

Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at


15 March 2024

Medical Research Future Fund team visits WA-based BMTH awardees

Recently, the WA Life Sciences Innovation Hub has been hosting site tours to WA-based companies that received funding through the BioMedTech Horizons (BMTH) programAdvanced Genetic Diagnostics, OncoRes Medical, Proteomics International, VitalTrace, Artrya, Cortical Dynamics, and ClearDrum, for WA-based team members of the Medical Research Future Fund (MRFF).

14 March 2024

Join Pharma Partnering Webinars with MSD and Viatris Ahead of BIO 2024

In the lead up to BIO 2024 in San Diego, Austrade is offering two interactive partnering webinars with MSD and Viatris’ US Business Development & Licensing teams, in April.

13 March 2024

BiVACOR Receives Funding Boost for Total Artificial Heart Clinical Trials

BiVACOR a clinical stage device company, recently received US$13 million as part of the Artificial Heart Frontiers Program, to support the company’s Total Artificial Heart program and future product enhancements. The funding will support clinical work of the BiVACOR Total Artificial Heart and begin development for the integration of wireless power sources for the device. Read more about this Targeted Translation Research Accelerator awardee and its innovative implant.

08 March 2024

Turbo-Charge Your Digital Innovation with ANDHealth’s ACTIVATE Accelerator

Calling all Victorian digital or connected health companies approaching proof of concept! ANDHealth has opened applications for Cohort 2 of ACTIVATE, a purpose-built accelerator program supported by LaunchVic. If you want to turbo-charge your investment and customer readiness, apply now.

07 March 2024

Apply Now: Fast-track your healthtech venture with the MedTech Actuator Accelerator

The MedTech Actuator Accelerator has opened applications for Cohort 9! If you are an early stage medtech, biotech or healthtech startup looking to fast-track your commercialisation journey, be sure to apply.

06 March 2024

Argenica Therapeutics launches Phase 2 trials into novel stroke therapy drug

Perth-based Argenica Therapeutics Limited is developing pioneering novel neuroprotective therapies designed to reduce brain damage after stroke and other severe brain injuries. The company recently announced initiation of a Phase 2 clinical trial for its novel drug, ARG-007, with the aim of reducing brain tissue damage post-stroke.

06 March 2024

In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in February

Check out what MTPConnect got up to in February!

06 March 2024

Medicines Repurposing Program Opens - Call for Candidate Medicine Nominations

The Australian Government Department of Health and Aged Care has commenced a new Medicines Repurposing Program (MRP) to expand treatment options and improve health outcomes for Australians. Nominate new candidate medicines now, and attend a webinar in March to find out more.

28 February 2024

WA Life Sciences Innovation Hub Seminar Explores Translating Complexity

The WA Life Sciences Innovation Hub invites you to join a special seminar event with international biotech consultant Dr Kate Hilyard on “Translating complexity - getting rid of the jargon that often puts barriers between us”.

27 February 2024

Helping You Prepare to Partner at BIO2024

Join MTPConnect for an online information session on 15 March 2024 to help you get ready for business partnering in 2024!

27 February 2024

Next Up: SA Insights Delves into the Healthtech Investment Landscape

Delve into the dynamic world of healthtech investment at Adelaide Intermediary Program’s upcoming SA Insights event in March 2024.

27 February 2024

Join the BioForum - Advancing Non-Animal Models in Biomedical Research

BioMelbourne Network is hosting a discussion about the transformative potential of non-animal models to study complex biological processes, advance science and generate over $1.5 billion in revenue and over 5,000 jobs in Australia by 2024.

23 February 2024

MTPConnect's Global Market Navigator Program Lifts Off in Adelaide

MTPConnect’s South Australian team has launched a new service called Global Market Navigator Program which is offering support to a select number of Adelaide City-based healthtech companies going global.

21 February 2024

Early Results are In – MTPConnect’s TTRA Program Delivering Strong Health and Economic Impact at Halfway Mark

A new report published today shows MTPConnect’s Targeted Translation Research Accelerator (TTRA) program is already delivering benefits and novel health solutions for Australian patients and the health sector – just over halfway through its duration. The $47 million TTRA program, an initiative of the Medical Research Future Fund (MRFF), was established by MTPConnect in 2020 to support translational research for the development of novel products and solutions for diabetes and cardiovascular disease – leading causes of death and disability in Australia.

14 February 2024

New Report: ANDHealth Accelerator Cracks Australia’s Commercialisation Code

Published by global independent consulting firm L.E.K. Consulting, the ‘Economic impact assessment of ANDHealth+ and Masterclass: ACCELERATE programs’ report found that funding invested into ANDHealth’s flagship accelerator, ANDHealth+, is giving a return on investment through economic growth and job creation for digital health SMEs.